A molecule from Boots, a brand name from Upjohn.

Motrin is an American brand name for a British discovery. English Wikipedia’s article on ibuprofen says the compound was discovered in 1961 in Nottingham by Stewart Adams and John Nicholson, working in the research department of Boots, with a patent application filed the same year. The company sold it in the United Kingdom from 1969 under the name Brufen. The generic name itself is a compression of chemistry: according to the American Chemical Society, as cited by Wikipedia, “ibuprofen” is built from isobutyl, propionic acid and phenyl.

The American name came from a Michigan company. The Upjohn Company, Wikipedia says, was established in 1886 in Hastings, Michigan, by Dr. William E. Upjohn, originally to make “friable” pills designed to crumble easily. An account of the brand on Upjohn Memories, a history site kept by former employees, says Upjohn bought the rights to sell the Boots compound in the United States and other countries, gained approval from the US Food and Drug Administration, and put it on sale in the United States in 1974 under the product name Motrin. Wikipedia, citing the FDA’s own application records, likewise dates the Motrin name in the United States to 1974.

Until 1989 Motrin was sold on prescription in the United States. The same former-employee account says the tablets were made at first in Building 41 at Upjohn’s site in Portage, Michigan, and that production later moved to the company’s plant in Puerto Rico.

The British side of the story has been marked in public. Wikipedia records that in November 2013 the Royal Society of Chemistry placed a blue plaque at Boots’ Beeston factory site in Nottingham recognising the company’s work on ibuprofen, and that a second plaque on Pennyfoot Street names Adams and Nicholson and the Boots research department where they worked. Motrin, in other words, has always been a name laid over somebody else’s molecule, and the brand’s identity has been built by the companies that sold it rather than the one that discovered it.

From Upjohn to McNeil, then Kenvue.

The name crossed to the shop shelf in two stages. Upjohn Memories says that in 1984, when ibuprofen became available without a prescription in the United States, Upjohn made the over-the-counter product but did not sell it under its own name: it was marketed by Bristol-Myers as Nuprin. Five years later Upjohn put its own brand on the shelf. The Pink Sheet reported on 15 May 1989 that Upjohn would use the Motrin name for its non-prescription ibuprofen, Motrin IB, with a roll-out of caplets planned for late May or early June. The trade weekly explained the naming decision as a matter of recognition: physicians and arthritis patients already knew the prescription brand. It added that Upjohn had consulted the FDA about using the Motrin name and about possible confusion between the prescription and over-the-counter versions, and that the new brand would meet Advil, Nuprin and Johnson & Johnson’s Medipren on the shelf.

Upjohn itself did not last much longer as an independent company. Wikipedia says Upjohn merged with the Swedish company Pharmacia AB in 1995 to form Pharmacia & Upjohn, citing the Los Angeles Times of 21 August 1995. Two years later the Motrin name changed hands in a trade of brands. The Tan Sheet reported on 9 June 1997 that Pharmacia & Upjohn and Johnson & Johnson had jointly announced an agreement on 5 June under which J&J received full rights to the Motrin analgesic franchise and the topical antibiotic Mycitracin, while Pharmacia & Upjohn took J&J’s Nasalcrom, PediaCare and Micatin. The Pharma Letter, on 10 June 1997, added that McNeil Consumer Products gained exclusive worldwide rights to over-the-counter Motrin and to prescription Motrin everywhere except the United States and Latin America, where the brand was licensed back to Pharmacia & Upjohn.

McNeil gave Motrin a sister brand. Wikipedia’s history of the company says McNeil Laboratories was formed in Philadelphia in 1933, that Johnson & Johnson acquired it in 1959, and that it moved into its Fort Washington, Pennsylvania, headquarters in 1961; it lists both Tylenol and Motrin among its brands. In 2018, according to the same article, Johnson & Johnson renamed the Fort Washington facility Johnson & Johnson Consumer Inc.

The latest change came with the separation of J&J’s consumer business. Wikipedia’s article on Kenvue, citing the Associated Press, says Johnson & Johnson announced on 12 November 2021 that it would spin off its consumer health division; the new company was named Kenvue in September 2022, held its initial public offering on 4 May 2023, and became fully separate after an exchange offer that J&J launched on 24 July 2023. Wikipedia lists Motrin among Kenvue’s brands and places the company’s headquarters in Summit, New Jersey. Kenvue has owned Motrin since 2023. On 3 November 2025, the Associated Press reported, Kimberly-Clark announced an agreement to acquire Kenvue.

Design and documentation.

Over-the-counter remedy brands live on a crowded shelf, and their identities have to work at the distance of an aisle and at the closeness of a medicine cabinet. Much of that work is done by colour: a carton colour held steady over many years, a tablet, caplet or liquid with a colour of its own, and a logotype set large enough to be read at a glance.

These brands also carry text that design does not control. Packs for remedies sold without a prescription usually include a regulatory panel whose layout, headings and wording are shaped by the rules of each market, so the brand’s own voice has to sit beside a block of standard information rather than replace it.

Sound has played a part as well. Radio and television advertising gave many remedy names a slogan or a jingle, and for some the tune became as recognisable as the pack. Each guide in this group sets out who started the brand, who owns it now and how its name, colours and advertising have changed, keeping to what dated sources record.

How a prescription brand became a shelf brand.

The most important design decision in Motrin’s history was a naming decision. When ibuprofen moved to the open shelf in the United States in 1984, its maker chose not to use its own brand: the Upjohn-made product went out as Nuprin under Bristol-Myers, while American Home Products launched Advil. By 1989, as The Pink Sheet reported it, Upjohn had changed course and decided that a name already trusted at the pharmacy counter was worth carrying out into the aisle. The letters “IB” were added to mark the non-prescription line, and the parent name stayed the same.

That choice tied two audiences to one word. The Pink Sheet framed the decision around physicians and arthritis patients who already knew the prescription form, and it recorded that Upjohn had discussed the name with the FDA because of the risk of confusion between the two versions. The brand that resulted had to work in two places at once: as a prescription product in medical settings and as a consumer pack among competing pain relievers. The suffix did the work of separating them while the main name did the work of recognition.

The 1997 swap then split the name by territory. Under the arrangement reported by The Pharma Letter, McNeil held the over-the-counter brand worldwide and the prescription brand outside the United States and Latin America, while Pharmacia & Upjohn kept prescription Motrin in those regions under licence. For several years the same word therefore belonged, in different markets and in different forms, to two companies. Under Johnson & Johnson, Motrin sat in the same Fort Washington portfolio as Tylenol, and in 2023 the two brands moved together into Kenvue.

Each owner has inherited the name rather than reinventing it. Upjohn chose it in 1974, kept it for the shelf in 1989 and traded it in 1997; McNeil and then Kenvue have carried it since. Through every change the brand has kept the same short, two-syllable word, which is why its identity is better read through its names and owners than through any single logo.

For a design guide, Motrin shows how a prescription name can be extended to the open shelf with a short suffix, letting one word serve two very different counters. Compare it with Tylenol, its McNeil stablemate, and Advil, which reached the shelf in 1984. For this guide we use signal red and navy with caplet orange on chalk with a sans, an unofficial interpretation; no product or logo is reproduced.

Keep Motrin’s identity on hand — save it to a board in the Made Good inspiration library.